Updated:
AdBio Partners
AdBio Partners is a Paris-based private equity firm active in early-stage venture.
AdBio Partners
AdBio Partners is a venture capital firm investing in early-stage life sciences companies in Europe. Founded in 2015 in Paris, France, the company was previously known as Advent France Biotechnology. AdBio Partners has made 31 investments, including a Series B investment in Tenpoint Therapeutics on January 28, 2026.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
France
City
Paris
Corporate office
Paris, France
Sector focus
Frequently asked questions
Who runs investment decisions at AdBio Partners?
No named principals or investment committee members are listed in available records.
What investment stages does AdBio Partners target?
Records show coverage of early stage seed, start-up, growth and general venture.
Does AdBio Partners participate in fund commitments or only direct deals?
No information on fund commitments versus direct deals is present in sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: